INmune Bio files for EMA orphan drug status for its RDEB cell therapy
Go back to INmune Bio files for EMA orphan drug status for its RDEB cell therapy| (NASDAQ: INMB) | Delayed: 2.51 +0.07 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $ | |||
| Open | $2.44 | 52 Week Low | $ | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.41 | EPS | $ | |||
| Volume | 493,912 | |||||
